City
Epaper

Indian pharmaceutical exports get reprieve from Trump’s reciprocal tariffs

By IANS | Updated: April 3, 2025 09:16 IST

New York, April 3 Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get ...

Open in App

New York, April 3 Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get a reprieve from President Donald Trump’s reciprocal tariffs, according to the White House.

The US is the largest importer of pharmaceuticals from India, bringing in products in the category worth $8.73 billion during the 2024 fiscal year, according to statistics cited by the India Brand Equity Foundation (IBEF).

IBEF said 31.5 per cent of India’s pharmaceutical exports went to the US.

The White House factsheet issued on Wednesday after Trump’s announcement of 26 per cent reciprocal tariffs on imports from India said that pharmaceuticals were exempt.

Indian drugs, especially the generics, help hold down the costs of the US healthcare system, which is already one of the most expensive in the world.

Previewing the likely outcomes of the tariffs, ING Bank had warned that “in the absence of a deal with India, we think Trump’s tariffs will mostly drive up drug prices for US consumers” because of the wide use of generics for which India is the major supplier.

Given the importance of Indian pharmaceuticals, President Trump has exempted that category even without a deal.

IQVIA, a healthcare data and analytics company, said that four out of ten prescriptions filled in the US in 2022 were from Indian companies.

“Out of the top 10 therapy areas by prescription volume, Indian companies supplied more than half of the prescriptions for five: hypertension, mental health, lipid regulators, nervous system disorders, and antiulcerants”, it said.

IQVIA estimated that by using generics from India, rather than high-priced branded products, the US healthcare system saved $219 billion in 2022 and a total of $1.3 trillion between 2013 and 2022.

These savings dwarf the dollar values of the pharmaceutical imports from India, and 26 per cent tariffs on them would have had a domino effect across the healthcare system, especially Medicare, the government healthcare insurance system for seniors, that is already facing challengee to long-rage viability.

The White House factsheet said that copper, semiconductors, lumber, bullion, energy and certain minerals that are not available in the US are also exempt from the reciprocal tariffs.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

EntertainmentShehnaaz Gill: ‘Ikk Kudi’ is the film I’ll carry with me all my life

NationalHardeep Puri recounts 1984 riots when Sikhs were attacked by ‘murderous mobs guided, led by Cong leaders'

NationalPM Modi, Sardar Patel's family pay tributes to India's 'Iron Man' on 150th birth anniv

MaharashtraMumbai Weather Update: City Wakes Up to Cloudy Skies and Fresh, Pollution-Free Air

EntertainmentShabana Azmi poses with her ‘do anmol ratan’ Farhan Akhtar, nephew Sagar

Business Realted Stories

BusinessApple clocks all-time revenue growth record in India in Sep quarter: Tim Cook

BusinessS. Korea unveils measures to boost critical mineral recycling amid global supply chain uncertainty

BusinessDeendayal Port Authority Kandla bags multiple 'Maritime Excellence Achievers Awards' at India Maritime Week 2025

BusinessUPI tops festive season payments, transactions jump to Rs 17.8 lakh crore: Bank of Baroda

BusinessGoogle CEO Sundar Pichai expresses enthusiasm over AI deal with Reliance, highlights benefits for Jio users